Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: The Efficacy of Susceptibility Test -Driven Sequential Therapy as the Third Line Therapy for Refractory Helicobacter Pylori Infection [Phase 4]
Phase 4 study from National Taiwan University Hospital completed evaluating susceptibility test–driven sequential therapy as a third-line tr…
-
FDA approval · 2012-05-18FDA Approved: BASIC CARE LANSOPRAZOLE — Original Application (Amazon.com Services LLC)
FDA approved a generic lansoprazole product, BASIC CARE LANSOPRAZOLE, under an original application by Amazon.com Services LLC. This provide…
-
FDA approval · 2012-05-18FDA Approved: LANSOPRAZOLE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved the original ANDA for lansoprazole from Dr. Reddy's Laboratories, authorizing a generic lansoprazole product.
-
FDA approval · 2012-05-11FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2012-05-08FDA Approved: ACIPHEX — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved Waylis Therapeutics LLC's supplemental application for ACIPHEX (rabeprazole sodium).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-04-18FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for lansoprazole, authorizing the marketing of a generic lansoprazole…
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
CLINICAL_TRIALS trial_result · 2012-04-10Clinical Trial Update: Comparison Between Ten Days Sequential Treatment and Traditional Three Combined Treatment of Helicobacter Pylori [Phase 4]
A Phase 4 study compares a 10-day sequential regimen to the traditional three-drug therapy for Helicobacter pylori infection; the trial has …
-
CLINICAL_TRIALS trial_result · 2012-04-06Clinical Trial Update: Increased Re-eradication Rate of Helicobacter Pylori by Adding N-acetylcystein or Metronidazole to the Triple Therapy [Phase 4]
A Phase 4 trial update reports that adding N-acetylcysteine or metronidazole to standard triple therapy may improve eradication rates of Hel…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Rabeprazole Based Sequential-Concommitant Hybrid Therapies for H. Pylori Infections [Phase 4]
Phase 4 clinical trial update evaluating rabeprazole-based sequential-concomitant hybrid therapies for Helicobacter pylori infection.
-
FDA approval · 2012-03-23FDA Approved: OMEPRAZOLE — Supplemental Application (Apotex Corp)
FDA approves Apotex Corp's supplemental application for omeprazole (generic) under ANDA076048. This authorizes the marketing of a generic om…
-
CLINICAL_TRIALS trial_result · 2012-03-06Clinical Trial Update: 5 Day Concomitant Versus 10 Day Sequential Therapy for Eradication of H. Pylori Infection [Phase 3]
Phase 3 trial comparing 5-day concomitant therapy to 10-day sequential therapy for Helicobacter pylori infection; study status is completed.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
CLINICAL_TRIALS trial_result · 2012-01-20Clinical Trial Update: New Dual Therapy for Primary Treatment of Helicobacter Pylori Infection：a Pilot Study [Phase 2]
A Phase 2 pilot trial evaluated a new dual therapy for the primary treatment of Helicobacter pylori infection in patients with functional dy…
-
FDA approval · 2012-01-20FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca, updating the labeling under a supplemental…
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Antimicrobial Susceptibility for Helicobacter Pylori Eradication
An update on a clinical trial investigating antimicrobial susceptibility for Helicobacter pylori eradication. The current status is unknown …
-
CLINICAL_TRIALS trial_result · 2011-10-10Clinical Trial Update: Supplementation With L. Reuteri in H. Pylori Infected Adults [NA]
A clinical trial update describing supplementation with Lactobacillus reuteri in adults infected with Helicobacter pylori to address dyspeps…
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors) [Phase 4]
Phase 4 clinical trial evaluating 13-C Urea Breath Test using BreathID and proton pump inhibitors for Helicobacter pylori infection; complet…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori Eradication [Phase 3]
This Phase 3 trial evaluated the efficacy and safety of levofloxacin-based triple therapy for Helicobacter pylori eradication. The study sta…
-
CLINICAL_TRIALS trial_result · 2011-08-02Clinical Trial Update: Comparison of Sequential or Concomitant Therapy for Helicobacter Pylori Infection [Phase 4]
Phase 4 clinical trial update comparing sequential versus concomitant antibiotic regimens for Helicobacter pylori infection.
-
CLINICAL_TRIALS research · 2011-06-22Clinical Trial Update: Control of Helicobacter Pylori Infection by Dietary Supplementation With Lactobacillus Reuteri [NA]
A clinical trial exploring whether Lactobacillus reuteri dietary supplementation can control Helicobacter pylori infection and related dyspe…
-
FDA approval · 2011-06-01FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add a Solutab formulation, submitted by Takeda Pharmaceut…